A
Arterys
Medical Imaging Cloud Platform
About Arterys
Arterys operates in the healthcare sector, specializing in medical imaging enhanced by artificial intelligence (AI). The company serves healthcare providers, including hospitals and clinics, by integrating AI-driven clinical applications into existing Picture Archiving and Communication Systems (PACS) or Electronic Health Records (EHR) workflows. This integration allows for seamless adoption of advanced diagnostic tools without disrupting current practices. Arterys' platform is cloud-based, ensuring accessibility from any validated device, which enhances performance and deployment ease while maintaining data security. The business model revolves around a subscription-based service, where clients pay for access to the AI tools and platform. Revenue is generated through these subscriptions and potentially through partnerships with other healthcare technology providers. The platform's key features include improved diagnostic accuracy, enhanced physician experience, and better financial performance for healthcare providers. Arterys aims to transform healthcare by leveraging deep learning and AI to extract actionable insights from medical images, thereby improving clinical decision-making, efficiency, and productivity.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2013
- Headquarters
- San Francisco, United States
- Employees
- 14
- Open positions
- None listed
- Dealroom signal
- 79.5/100
- Industry
- Health
- Sub-industry
- Medical Devices, Health Platform
- Sector
- Health Tech & Medtech, Cardiology and cardiovascular, Core AI, Spinout
- Technology
- Artificial Intelligence, Big Data, Deep Tech, Machine Learning, Deep Learning, Computer Vision
- Business model
- SaaS
- Client focus
- b2b
- Investment activity
- 1 company, latest Nov 2017
- Capital deployed
- $30M
- Preferred round
- SERIES B
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | May 2020 | $28M | $112M | Revelation Partners · Fosun Group · Varian Medical Systems · Emergent Medical Partners | ↗ |
| CONVERTIBLEOther financing | Jul 2019 | $0 | — | Asset Management Ventures | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Arterys is 3.4K monthly website visits, up 9.7% over the last three months. Arterys's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Asset Management Ventures
Farzad (Zod) Nazem
MedTech Innovator
Series A12 investors entered at this stage
GE Ventures- EPEmergent Medical Partners
AME Cloud Ventures
Norwich Ventures
Morado Ventures
StartX
Temasek
Varian Medical Systems- Arterys
ORI Capital
Northwell Health
New York Presbyterian Ventures
Series B and later2 investors entered at this stage
Revelation Partners
Fosun Group
Other known investors1 additional known investor
Stanford University
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Arterys on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Arterys’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.